Cite
Design of new dopamine D2 receptor ligands: Biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581
MLA
Pazini, Francine, et al. “Design of New Dopamine D2 Receptor Ligands: Biosynthesis and Pharmacological Evaluation of the Hydroxylated Metabolite of LASSBio-581.” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 9, May 2010, pp. 2888–91. EBSCOhost, https://doi.org/10.1016/j.bmcl.2010.03.034.
APA
Pazini, F., Menegatti, R., Sabino, J. R., Andrade, C. H., Neves, G., Rates, S. M. K., Noël, F., Fraga, C. A. M., Barreiro, E. J., & de Oliveira, V. (2010). Design of new dopamine D2 receptor ligands: Biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581. Bioorganic & Medicinal Chemistry Letters, 20(9), 2888–2891. https://doi.org/10.1016/j.bmcl.2010.03.034
Chicago
Pazini, Francine, Ricardo Menegatti, José R. Sabino, Carolina H. Andrade, Gilda Neves, Stela M.K. Rates, François Noël, Carlos A.M. Fraga, Eliezer J. Barreiro, and Valéria de Oliveira. 2010. “Design of New Dopamine D2 Receptor Ligands: Biosynthesis and Pharmacological Evaluation of the Hydroxylated Metabolite of LASSBio-581.” Bioorganic & Medicinal Chemistry Letters 20 (9): 2888–91. doi:10.1016/j.bmcl.2010.03.034.